Harmony Biosciences: Deutsche Bank raises target price to $42 from $39
HRMY•Deutsche Bank raised its target price for Harmony Biosciences to $42 from $39.
Related News
National Bank Holdings Corp: Piper Sandler cuts target price to $49 from $51
NBHC•
JPMorgan raises Marsh & McLennan target price to $215 from $212
MRSH•
Trump unveils $200 billion South Korean investment in US; Seoul hedges on Alaska pipeline
LNG•
Ares strengthens commitment to Plenitude through €1 billion capital contribution
ARES•
Europe research roundup: Barclays, Lloyds, NatWest Group
BCS•